US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CALIDI BIOTHERAPEUTICS INC

1.38

+0.04002.99%

Post-market: 1.29-0.0900-6.52%19:23 EDT

Volume:62.40K

Turnover:83.49K

Market Cap:3.57M

PE:-0.04

High:1.38

Open:1.34

Low:1.26

Close:1.34

52wk High:30.08

52wk Low:1.25

Shares:2.58M

Float Shares:2.56M

Volume Ratio:0.44

T/O Rate:2.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-33.3374

EPS(LYR):-95.1334

ROE:-672.22%

ROA:-134.79%

PB:1.14

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Calidi Biotherapeutics - Targets Cld-401 Regulatory Submission by Year-End, First-in-Human Trial in Early 2027

THOMSON REUTERS

Calidi Biotherapeutics - FDA and Calidi Agree on Cmc, Non-Clinical, and Study Design for Cld-401

THOMSON REUTERS

Calidi Biotherapeutics issues amended warrant for 17,391,304 shares at $0.23 in private placement

Calidi announces online abstract acceptances at 2026 ASCO Meeting

Calidi Biotherapeutics to present RedTail platform data at ASCO annual meeting

Calidi provides required NYSE American disclosure

Calidi flags going-concern note in 2025 audit report for NYSE American disclosure

Calidi Biotherapeutics Q1 EPS $(0.43) Beats $(1.56) Estimate

Benzinga Earnings

Calidi Biotherapeutics Q1 net loss narrows 19% to $4.11 million

Press Release: Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights

Calidi Biotherapeutics CSO presents RedTail platform at ASGCT conference

Calidi issues warrant for up to 17,391,304 shares at $0.23 in private placement

BRIEF-Calidi Biotherapeutics Announces Strategic Partnership With Transferai

Calidi Biotherapeutics partners with TransferAI to streamline CLD-401 IND submission

Calidi Biotherapeutics Announces Strategic Partnership With Transferai to Drive Efficiencies in the Ind Submission Process for Cld-401 Using Agentic AI

THOMSON REUTERS

Calidi Biotherapeutics Inc - Expects Cld-401 Ind Filing by Year End

THOMSON REUTERS

Calidi Biotherapeutics publishes RedTail platform presentation on systemic genetic medicine delivery

Calidi presents new data on CLD-401 at AACR

Calidi presents new data on in situ t-cell engagers at AACR

Calidi presents preclinical data for RedTail-derived CLD-401, targets IND filing end-2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/CLDI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CLDI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLDI\",,,,,undefined,":{"symbol":"CLDI","market":"US","secType":"STK","nameCN":"CALIDI BIOTHERAPEUTICS INC","latestPrice":1.38,"timestamp":1787601600000,"preClose":1.34,"halted":0,"volume":62402,"hourTrading":{"tag":"盘后","latestPrice":1.29,"preClose":1.38,"latestTime":"19:23 EDT","volume":1063,"amount":1435.226,"timestamp":1787613797223,"change":-0.09,"changeRate":-0.065217,"amplitude":0.065217},"delay":0,"changeRate":0.029850746268656577,"floatShares":2555400,"shares":2584200,"eps":-33.337368,"marketStatus":"Not Yet Opened","change":0.04,"latestTime":"08-24 16:00:00 EDT","open":1.34,"high":1.38,"low":1.26,"amount":83492.3221902,"amplitude":0.089552,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-33.337368,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"exchange":"AMEX","adjPreClose":1.34,"preHourTrading":{"tag":"盘前","latestPrice":1.35,"preClose":1.34,"latestTime":"09:11 EDT","volume":6507,"amount":8801.9154387,"timestamp":1787577073265,"change":0.01,"changeRate":0.007463,"amplitude":0.106269},"postHourTrading":{"tag":"盘后","latestPrice":1.29,"preClose":1.38,"latestTime":"19:23 EDT","volume":1063,"amount":1435.226,"timestamp":1787613797223,"change":-0.09,"changeRate":-0.065217,"amplitude":0.065217},"volumeRatio":0.438809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLDI\",,,,,undefined,":{"symbol":"CLDI","floatShares":2555400,"roa":"-134.79%","roe":"-672.22%","lyrEps":-95.133424,"volumeRatio":0.438809,"shares":2584200,"dividePrice":0,"high":1.38,"amplitude":0.089552,"preClose":1.34,"low":1.26,"week52Low":1.25,"pbRate":"1.14","week52High":30.08,"institutionHeld":0,"latestPrice":1.38,"eps":-33.337368,"divideRate":0,"volume":62402,"delay":0,"ttmEps":-33.337368,"open":1.34,"prevYearClose":18.72,"prevWeekClose":1.34,"prevMonthClose":1.64,"prevQuarterClose":2.72,"fiveDayClose":1.36,"twentyDayClose":1.752,"sixtyDayClose":3.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLDI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-31","symbol":"CLDI","defaultRemindTime":1785504600000,"type":"split","dateTimestamp":1785470400000,"forFactor":16,"toFactor":1,"ratio":16},{"market":"US","date":"2025-08-05","symbol":"CLDI","defaultRemindTime":1754400600000,"type":"split","dateTimestamp":1754366400000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2024-07-15","symbol":"CLDI","defaultRemindTime":1721050200000,"type":"split","dateTimestamp":1721016000000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLDI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLDI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLDI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLDI","date":"2026-08-21","current":-0.041395,"percent":0.836676,"low":-6.02184,"twenty":-0.987327,"median":-0.481003,"eighty":-0.292874,"high":-0.088409,"avg":-0.723921,"sd":0.723661,"marketCap":3475369},"quantilePoints":[{"date":"2023-09-29","current":-3.638343,"twenty":-5.308141,"median":-4.713391,"eighty":-4.212002,"marketCap":116696199},{"date":"2023-10-06","current":-3.412521,"twenty":-4.832341,"median":-4.127586,"eighty":-3.638343,"marketCap":109453210},{"date":"2023-10-13","current":-3.406945,"twenty":-4.642021,"median":-3.525432,"eighty":-3.367913,"marketCap":109274365},{"date":"2023-10-20","current":-3.122569,"twenty":-4.220957,"median":-3.406945,"eighty":-3.283158,"marketCap":100153264},{"date":"2023-10-27","current":-2.788008,"twenty":-3.847474,"median":-3.379065,"eighty":-3.220707,"marketCap":89422557},{"date":"2023-11-03","current":-1.828933,"twenty":-3.642821,"median":-3.289849,"eighty":-2.58281,"marketCap":58661197},{"date":"2023-11-10","current":-2.263862,"twenty":-3.457685,"median":-3.122569,"eighty":-2.272784,"marketCap":72611116},{"date":"2023-11-17","current":-2.442295,"twenty":-3.40806,"median":-2.704368,"eighty":-2.257171,"marketCap":78334160},{"date":"2023-11-24","current":-2.219166,"twenty":-3.390217,"median":-2.436719,"eighty":-2.230406,"marketCap":63785485},{"date":"2023-12-01","current":-2.589027,"twenty":-3.358991,"median":-2.397687,"eighty":-2.219166,"marketCap":74416400},{"date":"2023-12-08","current":-2.860258,"twenty":-3.332227,"median":-2.436719,"eighty":-2.22591,"marketCap":82212403},{"date":"2023-12-15","current":-2.835601,"twenty":-3.283158,"median":-2.620727,"eighty":-2.230406,"marketCap":81503676},{"date":"2023-12-22","current":-2.220879,"twenty":-3.249702,"median":-2.454969,"eighty":-2.220879,"marketCap":63834719},{"date":"2023-12-29","current":-1.739688,"twenty":-3.220707,"median":-2.431143,"eighty":-2.219509,"marketCap":50003863},{"date":"2024-01-05","current":-1.752027,"twenty":-3.147103,"median":-2.407056,"eighty":-2.219166,"marketCap":50358500},{"date":"2024-01-12","current":-1.628644,"twenty":-3.080391,"median":-2.314664,"eighty":-2.158893,"marketCap":46812127},{"date":"2024-01-19","current":-1.492924,"twenty":-2.974346,"median":-2.305467,"eighty":-1.939518,"marketCap":42911116},{"date":"2024-01-26","current":-1.204827,"twenty":-2.880427,"median":-2.269438,"eighty":-1.766833,"marketCap":34630335},{"date":"2024-02-02","current":-0.987855,"twenty":-2.845464,"median":-2.230406,"eighty":-1.702674,"marketCap":28393922},{"date":"2024-02-09","current":-0.730889,"twenty":-2.828204,"median":-2.220879,"eighty":-1.569421,"marketCap":21007953},{"date":"2024-02-16","current":-0.617286,"twenty":-2.802114,"median":-2.220879,"eighty":-1.222224,"marketCap":17742652},{"date":"2024-02-23","current":-1.223953,"twenty":-2.75773,"median":-2.219166,"eighty":-1.201248,"marketCap":35180069},{"date":"2024-03-01","current":-0.737187,"twenty":-2.712314,"median":-2.219166,"eighty":-1.144986,"marketCap":21188964},{"date":"2024-03-08","current":-0.857685,"twenty":-2.707382,"median":-2.174646,"eighty":-1.007118,"marketCap":24652427},{"date":"2024-03-15","current":-0.752972,"twenty":-2.675328,"median":-2.00496,"eighty":-0.959654,"marketCap":21642662},{"date":"2024-03-22","current":-0.731293,"twenty":-2.63341,"median":-1.828933,"eighty":-0.834401,"marketCap":21365466},{"date":"2024-03-28","current":-0.690544,"twenty":-2.624956,"median":-1.776703,"eighty":-0.788933,"marketCap":20174941},{"date":"2024-04-05","current":-0.515506,"twenty":-2.614387,"median":-1.733519,"eighty":-0.77599,"marketCap":15061018},{"date":"2024-04-12","current":-0.778003,"twenty":-2.56475,"median":-1.702674,"eighty":-0.753894,"marketCap":22730126},{"date":"2024-04-19","current":-0.277851,"twenty":-2.462573,"median":-1.585461,"eighty":-0.73922,"marketCap":8117685},{"date":"2024-04-26","current":-0.277851,"twenty":-2.440065,"median":-1.494131,"eighty":-0.729834,"marketCap":8117685},{"date":"2024-05-03","current":-0.33683,"twenty":-2.428199,"median":-1.326872,"eighty":-0.713833,"marketCap":9840816},{"date":"2024-05-10","current":-0.388779,"twenty":-2.412677,"median":-1.223953,"eighty":-0.694949,"marketCap":11358553},{"date":"2024-05-17","current":-0.395215,"twenty":-2.384304,"median":-1.201804,"eighty":-0.67322,"marketCap":11848146},{"date":"2024-05-24","current":-0.389826,"twenty":-2.327552,"median":-1.110439,"eighty":-0.59822,"marketCap":11686581},{"date":"2024-05-31","current":-0.489936,"twenty":-2.314664,"median":-1.049596,"eighty":-0.481812,"marketCap":14687785},{"date":"2024-06-07","current":-0.316825,"twenty":-2.30847,"median":-0.987793,"eighty":-0.405177,"marketCap":9498101},{"date":"2024-06-14","current":-0.471065,"twenty":-2.306068,"median":-0.973968,"eighty":-0.411637,"marketCap":14122049},{"date":"2024-06-21","current":-0.417535,"twenty":-2.287195,"median":-0.942383,"eighty":-0.415168,"marketCap":12517271},{"date":"2024-06-28","current":-0.442801,"twenty":-2.275014,"median":-0.891807,"eighty":-0.416445,"marketCap":13274726},{"date":"2024-07-05","current":-0.415179,"twenty":-2.275014,"median":-0.841776,"eighty":-0.414794,"marketCap":12446661},{"date":"2024-07-12","current":-0.324606,"twenty":-2.266092,"median":-0.802632,"eighty":-0.404243,"marketCap":9731376},{"date":"2024-07-15","current":-0.338952,"twenty":-2.263862,"median":-0.798467,"eighty":-0.400509,"marketCap":10161455},{"date":"2024-08-02","current":-0.357581,"twenty":-2.257171,"median":-0.794302,"eighty":-0.396487,"marketCap":10719918},{"date":"2024-08-09","current":-0.398883,"twenty":-2.230406,"median":-0.779498,"eighty":-0.390904,"marketCap":11958114},{"date":"2024-08-16","current":-0.480755,"twenty":-2.230406,"median":-0.778003,"eighty":-0.392451,"marketCap":11175142},{"date":"2024-08-23","current":-0.500804,"twenty":-2.228501,"median":-0.759804,"eighty":-0.395268,"marketCap":11641180},{"date":"2024-08-30","current":-0.382558,"twenty":-2.220879,"median":-0.750634,"eighty":-0.391354,"marketCap":8892568},{"date":"2024-09-06","current":-0.39647,"twenty":-2.220879,"median":-0.737187,"eighty":-0.391253,"marketCap":9215934},{"date":"2024-09-13","current":-0.403425,"twenty":-2.220879,"median":-0.730361,"eighty":-0.39176,"marketCap":9377617},{"date":"2024-09-20","current":-0.384297,"twenty":-2.220879,"median":-0.726938,"eighty":-0.391253,"marketCap":8932989},{"date":"2024-09-27","current":-0.420814,"twenty":-2.219166,"median":-0.713995,"eighty":-0.389826,"marketCap":9781825},{"date":"2024-10-04","current":-0.375603,"twenty":-2.219166,"median":-0.705506,"eighty":-0.388779,"marketCap":8730885},{"date":"2024-10-11","current":-0.484689,"twenty":-2.219166,"median":-0.691943,"eighty":-0.386036,"marketCap":11266594},{"date":"2024-10-18","current":-0.559329,"twenty":-2.219166,"median":-0.675446,"eighty":-0.386036,"marketCap":13001597},{"date":"2024-10-25","current":-0.336452,"twenty":-2.219166,"median":-0.638834,"eighty":-0.386036,"marketCap":7820838},{"date":"2024-10-31","current":-0.530552,"twenty":-2.18355,"median":-0.601504,"eighty":-0.386036,"marketCap":12332679},{"date":"2024-11-08","current":-0.740861,"twenty":-2.174646,"median":-0.630927,"eighty":-0.38823,"marketCap":17221309},{"date":"2024-11-15","current":-0.849939,"twenty":-2.111632,"median":-0.664773,"eighty":-0.389367,"marketCap":22332149},{"date":"2024-11-22","current":-1.580558,"twenty":-2.067561,"median":-0.675446,"eighty":-0.389764,"marketCap":41529165},{"date":"2024-11-29","current":-1.558504,"twenty":-1.993856,"median":-0.690544,"eighty":-0.390682,"marketCap":40949688},{"date":"2024-12-06","current":-1.477638,"twenty":-1.934558,"median":-0.69736,"eighty":-0.391557,"marketCap":38824940},{"date":"2024-12-13","current":-1.374718,"twenty":-1.867215,"median":-0.712804,"eighty":-0.392499,"marketCap":36120716},{"date":"2024-12-20","current":-1.065958,"twenty":-1.812401,"median":-0.717637,"eighty":-0.394326,"marketCap":28008041},{"date":"2024-12-27","current":-1.088012,"twenty":-1.791509,"median":-0.728386,"eighty":-0.395322,"marketCap":28587518},{"date":"2025-01-03","current":-0.867469,"twenty":-1.774231,"median":-0.730361,"eighty":-0.39568,"marketCap":22792751},{"date":"2025-01-10","current":-0.992443,"twenty":-1.764344,"median":-0.73424,"eighty":-0.39647,"marketCap":26076452},{"date":"2025-01-17","current":-0.658321,"twenty":-1.752027,"median":-0.729834,"eighty":-0.39647,"marketCap":17297380},{"date":"2025-01-24","current":-0.559444,"twenty":-1.742156,"median":-0.726938,"eighty":-0.39647,"marketCap":14699393},{"date":"2025-01-31","current":-0.459906,"twenty":-1.730007,"median":-0.713995,"eighty":-0.3984,"marketCap":12084021},{"date":"2025-02-07","current":-1.088012,"twenty":-1.727397,"median":-0.721011,"eighty":-0.399734,"marketCap":28587518},{"date":"2025-02-14","current":-0.992443,"twenty":-1.707609,"median":-0.729834,"eighty":-0.399947,"marketCap":26076452},{"date":"2025-02-21","current":-0.926281,"twenty":-1.702674,"median":-0.731091,"eighty":-0.399947,"marketCap":24338022},{"date":"2025-02-28","current":-0.612521,"twenty":-1.691156,"median":-0.729834,"eighty":-0.399947,"marketCap":16094000},{"date":"2025-03-07","current":-0.624578,"twenty":-1.650578,"median":-0.723974,"eighty":-0.400284,"marketCap":16410780},{"date":"2025-03-14","current":-0.571942,"twenty":-1.617436,"median":-0.713824,"eighty":-0.401215,"marketCap":15027763},{"date":"2025-03-21","current":-0.580763,"twenty":-1.605553,"median":-0.709155,"eighty":-0.402729,"marketCap":15259553},{"date":"2025-03-28","current":-0.511219,"twenty":-1.596023,"median":-0.693342,"eighty":-0.403425,"marketCap":13432270},{"date":"2025-04-04","current":-0.459715,"twenty":-1.584987,"median":-0.688902,"eighty":-0.403425,"marketCap":10179474},{"date":"2025-04-11","current":-0.669232,"twenty":-1.579798,"median":-0.693063,"eighty":-0.404476,"marketCap":14818796},{"date":"2025-04-17","current":-0.762727,"twenty":-1.576858,"median":-0.698757,"eighty":-0.405589,"marketCap":16889069},{"date":"2025-04-25","current":-0.815708,"twenty":-1.567326,"median":-0.703771,"eighty":-0.407877,"marketCap":18062224},{"date":"2025-05-02","current":-0.791432,"twenty":-1.558504,"median":-0.712804,"eighty":-0.410381,"marketCap":17524679},{"date":"2025-05-09","current":-0.680714,"twenty":-1.556948,"median":-0.713079,"eighty":-0.410531,"marketCap":15073040},{"date":"2025-05-16","current":-0.757287,"twenty":-1.55323,"median":-0.713725,"eighty":-0.411705,"marketCap":15073040},{"date":"2025-05-23","current":-0.755462,"twenty":-1.548212,"median":-0.715532,"eighty":-0.413178,"marketCap":15036720},{"date":"2025-05-30","current":-0.635937,"twenty":-1.533867,"median":-0.715532,"eighty":-0.413252,"marketCap":12657684},{"date":"2025-06-06","current":-0.601845,"twenty":-1.49389,"median":-0.713725,"eighty":-0.413637,"marketCap":11979114},{"date":"2025-06-13","current":-0.579566,"twenty":-1.491337,"median":-0.71226,"eighty":-0.415179,"marketCap":11535691},{"date":"2025-06-20","current":-0.49788,"twenty":-1.484989,"median":-0.706232,"eighty":-0.415179,"marketCap":9909811},{"date":"2025-06-27","current":-0.38649,"twenty":-1.477638,"median":-0.701377,"eighty":-0.415179,"marketCap":7692700},{"date":"2025-07-03","current":-0.414844,"twenty":-1.438928,"median":-0.693342,"eighty":-0.413227,"marketCap":8257056},{"date":"2025-07-11","current":-1.684355,"twenty":-1.438928,"median":-0.693202,"eighty":-0.413227,"marketCap":33525394},{"date":"2025-07-18","current":-1.123887,"twenty":-1.426793,"median":-0.701377,"eighty":-0.413252,"marketCap":22369845},{"date":"2025-07-25","current":-1.408554,"twenty":-1.420297,"median":-0.706232,"eighty":-0.414526,"marketCap":28035855},{"date":"2025-08-01","current":-1.087209,"twenty":-1.418827,"median":-0.712804,"eighty":-0.414844,"marketCap":21639801},{"date":"2025-08-08","current":-0.875894,"twenty":-1.410609,"median":-0.713774,"eighty":-0.415112,"marketCap":17433803},{"date":"2025-08-15","current":-0.869891,"twenty":-1.399128,"median":-0.7168,"eighty":-0.415179,"marketCap":17269086},{"date":"2025-08-22","current":-0.293416,"twenty":-1.396772,"median":-0.714044,"eighty":-0.415112,"marketCap":5824890},{"date":"2025-08-29","current":-0.333904,"twenty":-1.384858,"median":-0.713355,"eighty":-0.413227,"marketCap":6628654},{"date":"2025-09-05","current":-0.306566,"twenty":-1.377583,"median":-0.711715,"eighty":-0.410381,"marketCap":6085957},{"date":"2025-09-12","current":-0.318282,"twenty":-1.365896,"median":-0.706232,"eighty":-0.404476,"marketCap":6318541},{"date":"2025-09-19","current":-0.308519,"twenty":-1.353336,"median":-0.701377,"eighty":-0.401215,"marketCap":6124721},{"date":"2025-09-26","current":-0.294091,"twenty":-1.33881,"median":-0.693202,"eighty":-0.399947,"marketCap":5838288},{"date":"2025-10-03","current":-0.316401,"twenty":-1.31392,"median":-0.68726,"eighty":-0.39647,"marketCap":6281193},{"date":"2025-10-10","current":-0.322486,"twenty":-1.292622,"median":-0.675448,"eighty":-0.392499,"marketCap":6401985},{"date":"2025-10-17","current":-0.326542,"twenty":-1.284205,"median":-0.672663,"eighty":-0.38922,"marketCap":6482513},{"date":"2025-10-24","current":-0.308288,"twenty":-1.276188,"median":-0.670475,"eighty":-0.387098,"marketCap":6120137},{"date":"2025-10-31","current":-0.320457,"twenty":-1.271824,"median":-0.660381,"eighty":-0.385104,"marketCap":6361721},{"date":"2025-11-07","current":-0.336683,"twenty":-1.27075,"median":-0.656627,"eighty":-0.382558,"marketCap":6683833},{"date":"2025-11-14","current":-0.308288,"twenty":-1.248314,"median":-0.646559,"eighty":-0.37908,"marketCap":6120137},{"date":"2025-11-21","current":-0.506264,"twenty":-1.227901,"median":-0.642788,"eighty":-0.378051,"marketCap":10098454},{"date":"2025-11-28","current":-0.553956,"twenty":-1.216303,"median":-0.637388,"eighty":-0.378665,"marketCap":11049758},{"date":"2025-12-05","current":-0.564962,"twenty":-1.204728,"median":-0.625828,"eighty":-0.37908,"marketCap":11269290},{"date":"2025-12-12","current":-0.539282,"twenty":-1.202359,"median":-0.624725,"eighty":-0.379407,"marketCap":10757049},{"date":"2025-12-19","current":-0.480584,"twenty":-1.198139,"median":-0.617286,"eighty":-0.380537,"marketCap":9586214},{"date":"2025-12-26","current":-0.473247,"twenty":-1.193728,"median":-0.613551,"eighty":-0.381709,"marketCap":9439860},{"date":"2026-01-02","current":-0.429224,"twenty":-1.181411,"median":-0.606978,"eighty":-0.382558,"marketCap":8561733},{"date":"2026-01-09","current":-0.425556,"twenty":-1.152719,"median":-0.601338,"eighty":-0.382558,"marketCap":8488556},{"date":"2026-01-16","current":-0.381533,"twenty":-1.123887,"median":-0.596031,"eighty":-0.382558,"marketCap":7610429},{"date":"2026-01-23","current":-0.381533,"twenty":-1.113129,"median":-0.591212,"eighty":-0.381526,"marketCap":7610429},{"date":"2026-01-30","current":-0.385201,"twenty":-1.10426,"median":-0.583111,"eighty":-0.37908,"marketCap":7683607},{"date":"2026-02-06","current":-0.308931,"twenty":-1.10252,"median":-0.580763,"eighty":-0.3778,"marketCap":6162252},{"date":"2026-02-13","current":-0.278812,"twenty":-1.090904,"median":-0.575754,"eighty":-0.374195,"marketCap":5561467},{"date":"2026-02-20","current":-0.26843,"twenty":-1.088012,"median":-0.566497,"eighty":-0.373137,"marketCap":5354376},{"date":"2026-02-27","current":-0.310362,"twenty":-1.08753,"median":-0.56401,"eighty":-0.369399,"marketCap":6190791},{"date":"2026-03-06","current":-0.282371,"twenty":-1.0848,"median":-0.559387,"eighty":-0.36189,"marketCap":5632449},{"date":"2026-03-13","current":-0.174784,"twenty":-1.08267,"median":-0.557624,"eighty":-0.357961,"marketCap":3486416},{"date":"2026-03-20","current":-0.158448,"twenty":-1.081325,"median":-0.553956,"eighty":-0.344782,"marketCap":3160553},{"date":"2026-03-27","current":-0.148693,"twenty":-1.078568,"median":-0.550287,"eighty":-0.336771,"marketCap":2965985},{"date":"2026-04-02","current":-0.134617,"twenty":-1.073376,"median":-0.545256,"eighty":-0.334923,"marketCap":2679692},{"date":"2026-04-10","current":-0.142941,"twenty":-1.067403,"median":-0.543606,"eighty":-0.331139,"marketCap":2845378},{"date":"2026-04-17","current":-0.153817,"twenty":-1.066944,"median":-0.540074,"eighty":-0.327107,"marketCap":3061874},{"date":"2026-04-24","current":-0.122077,"twenty":-1.066514,"median":-0.537448,"eighty":-0.325201,"marketCap":2430059},{"date":"2026-05-01","current":-0.13151,"twenty":-1.065958,"median":-0.535582,"eighty":-0.324514,"marketCap":2617836},{"date":"2026-05-08","current":-0.120135,"twenty":-1.065958,"median":-0.532096,"eighty":-0.32282,"marketCap":2391399},{"date":"2026-05-15","current":-0.14671,"twenty":-1.063017,"median":-0.526887,"eighty":-0.322188,"marketCap":2920400},{"date":"2026-05-22","current":-0.155096,"twenty":-1.055002,"median":-0.522094,"eighty":-0.320457,"marketCap":2951158},{"date":"2026-05-29","current":-0.15356,"twenty":-1.046879,"median":-0.517003,"eighty":-0.317116,"marketCap":2921938},{"date":"2026-06-05","current":-0.140629,"twenty":-1.031095,"median":-0.513601,"eighty":-0.31633,"marketCap":2675880},{"date":"2026-06-12","current":-0.136588,"twenty":-1.010842,"median":-0.511292,"eighty":-0.314373,"marketCap":2598987},{"date":"2026-06-18","current":-0.122848,"twenty":-1.008527,"median":-0.506543,"eighty":-0.312424,"marketCap":2337551},{"date":"2026-06-26","current":-0.153214,"twenty":-1.002903,"median":-0.500804,"eighty":-0.312345,"marketCap":2915351},{"date":"2026-07-02","current":-0.161601,"twenty":-1.000417,"median":-0.498226,"eighty":-0.310311,"marketCap":3074936},{"date":"2026-07-10","current":-0.153111,"twenty":-0.999795,"median":-0.493476,"eighty":-0.308473,"marketCap":2913405},{"date":"2026-07-17","current":-0.118234,"twenty":-0.999795,"median":-0.489941,"eighty":-0.308288,"marketCap":2249763},{"date":"2026-07-24","current":-0.107393,"twenty":-0.993913,"median":-0.489211,"eighty":-0.304549,"marketCap":2043470},{"date":"2026-07-31","current":-0.095426,"twenty":-0.992443,"median":-0.486947,"eighty":-0.304232,"marketCap":1815768},{"date":"2026-08-07","current":-0.114424,"twenty":-0.98969,"median":-0.484689,"eighty":-0.301652,"marketCap":2177268},{"date":"2026-08-14","current":-0.098443,"twenty":-0.987781,"median":-0.481792,"eighty":-0.298405,"marketCap":1873180},{"date":"2026-08-21","current":-0.198899,"twenty":-0.987327,"median":-0.481003,"eighty":-0.292874,"marketCap":3475369}],"updateTime":1787642021914},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLDI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643541017","title":"Calidi Biotherapeutics - Targets Cld-401 Regulatory Submission by Year-End, First-in-Human Trial in Early 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2643541017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643541017?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:00","pubTimestamp":1781611200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUA6C20TQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643175754","title":"Calidi Biotherapeutics - FDA and Calidi Agree on Cmc, Non-Clinical, and Study Design for Cld-401","url":"https://stock-news.laohu8.com/highlight/detail?id=2643175754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643175754?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:00","pubTimestamp":1781611200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUA6C20TQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639711677","title":"Calidi Biotherapeutics issues amended warrant for 17,391,304 shares at $0.23 in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2639711677","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639711677?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:01","pubTimestamp":1780088487,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics issued an amended and restated warrant in a private placement to an accredited investor on May 28, 2026.The warrant covers up to 17,391,304 unvested common shares at an exercise price of $0.23.The minimum vesting acquisition amount increased to $1 million from $500,000.The vesting termination date moved to Sept. 30, 2026 from July 8, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calidi Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL8hRRs3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638546501","title":"Calidi announces online abstract acceptances at 2026 ASCO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638546501","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638546501?lang=en_us&edition=fundamental","pubTime":"2026-05-26 23:37","pubTimestamp":1779809840,"startTime":"0","endTime":"0","summary":"Calidi (CLDI) Biotherapeutics announced that two abstracts showcasing the Company’s RedTail platform have been accepted for online publication at t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calidi-announces-online-abstract-acceptances-at-2026-asco-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calidi-announces-online-abstract-acceptances-at-2026-asco-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638051457","title":"Calidi Biotherapeutics to present RedTail platform data at ASCO annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638051457","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638051457?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:05","pubTimestamp":1779797140,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics will have two RedTail platform abstracts published online for the 2026 ASCO Annual Meeting, May 29 to June 2, 2026, in Chicago.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLzj1jK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4112","NDAQ","LU2095319765.USD","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","CLDI","BK4585","SG9999014013.SGD","LU2210149790.SGD","BK4588","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637834750","title":"Calidi provides required NYSE American disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2637834750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637834750?lang=en_us&edition=fundamental","pubTime":"2026-05-23 06:05","pubTimestamp":1779487557,"startTime":"0","endTime":"0","summary":"Calidi (CLDI) Biotherapeutics advised that its Financial Statements included in its Annual Report on Form 10-K for the year ended December 31, 2025...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calidi-provides-required-nyse-american-disclosure-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calidi-provides-required-nyse-american-disclosure-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AFG","CLDI","BK4139","BK4107","BK4117","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637898347","title":"Calidi flags going-concern note in 2025 audit report for NYSE American disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2637898347","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637898347?lang=en_us&edition=fundamental","pubTime":"2026-05-23 06:00","pubTimestamp":1779487220,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics flagged that its 2025 Form 10-K audit report includes a going-concern explanatory paragraph.The disclosure was issued to meet NYSE American Section 610 requirements.The notice stated it does not reflect any change or amendment to the company’s 2025 filings.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDLMFxbw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4585","LU2210150020.SGD","BK4588","CLDI","LU2210149790.SGD","BK4112","NDAQ","BK4139","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD","SG9999014021.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635729347","title":"Calidi Biotherapeutics Q1 EPS $(0.43) Beats $(1.56) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635729347","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635729347?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:58","pubTimestamp":1778792300,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics (AMEX:CLDI) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(1.56) by 72.44 percent. This is a 80.09 percent increase over losses of $(2.16) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52583409/calidi-biotherapeutics-q1-eps-0-43-beats-1-56-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Calidi Biotherapeutics Q1 EPS $(0.43) Beats $(1.56) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635438726","title":"Calidi Biotherapeutics Q1 net loss narrows 19% to $4.11 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635438726","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635438726?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:42","pubTimestamp":1778791379,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics posted a net loss of $4.11 million for the quarter ended March 31, 2026, narrowing 19% from a year earlier.Operating loss improved 17% to $4.19 million, while total operating expenses fell 17% to $4.19 million.Research and development expense rose 7% to $2.59 million, while general and administrative costs dropped 39% to $1.6 million.Cash totaled $6.6 million at March 31, 2026, and management said it lacks sufficient cash to fund operations for at least one year, raising substantial doubt about its ability to continue as a going concern.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calidi Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gatherin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDLb8GdYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635725302","title":"Press Release: Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2635725302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635725302?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:10","pubTimestamp":1778789400,"startTime":"0","endTime":"0","summary":"-- Presented new data on CLD-401 at the AACR conference in San Diego, CA,detailing the profound immune changes in the tumor microenvironment. induced by CLD-401; IND filing for CLD-401 expected by end of 2026. detailing the use of the RedTail platform to create in vivo T-cell. engagers that simultaneously express both a T-cell engager and a T-cell. activator at high levels exclusively in the tumor microenvironment;presented new data on CLD-501, a TROP-2 in vivo T-cell engager. -- Demonstrated $1 million reduction in general and administrative expenses. IL15-SA expression may dramatically expand the therapeutic window of. \"We are excited about the continued progress at Calidi,\" said Eric Poma, PhD, Calidi Biotherapeutics CEO. \"We continue to advance CLD-401, the first lead from our RedTail platform, towards the clinic and have built a world-class scientific advisory board to aid those efforts. We have also expanded what the RedTail platform can do with our new approach of in situ T-cell","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDI","IND","EEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635278450","title":"Calidi Biotherapeutics CSO presents RedTail platform at ASGCT conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2635278450","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635278450?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:04","pubTimestamp":1778673841,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics to present at American Society for Gene and Cell Therapy annual conference in Boston on May 14.Chief Scientific Officer Antonio F. Santidrian scheduled to outline RedTail systemic virotherapy platform, including new data on lead program CLD-401.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL8SKMfV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4585","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4139","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","BK4588","CLDI","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467463","title":"Calidi issues warrant for up to 17,391,304 shares at $0.23 in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467463","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467463?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:18","pubTimestamp":1778275097,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics issued an unregistered warrant in a private placement on May 6, 2026 to an accredited investor for up to 17,391,304 shares of common stock at an exercise price of $0.23.Warrant becomes exercisable on Sept. 8, 2026, with vesting tied to any registered common stock purchases by holder of up to $4 million through July 8, 2026.Transaction has no commitment for either side to complete any share issuances tied to the vesting schedule.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calidi Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 08, 2026, an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL3X8gY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631519415","title":"BRIEF-Calidi Biotherapeutics Announces Strategic Partnership With Transferai","url":"https://stock-news.laohu8.com/highlight/detail?id=2631519415","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631519415?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:19","pubTimestamp":1777465171,"startTime":"0","endTime":"0","summary":"BRIEF-Calidi Biotherapeutics Announces Strategic Partnership With Transferai April 29 (Reuters) - Calidi Biotherapeutics Inc CLDI.A:CALIDI BIOTHERAPEUTICS ANNOUNCES STRATEGIC PARTNERSHIP WITH TRANSFER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUA6HJFSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631516027","title":"Calidi Biotherapeutics partners with TransferAI to streamline CLD-401 IND submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2631516027","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631516027?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:08","pubTimestamp":1777464488,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics entered collaboration with TransferAI to streamline IND submission process for CLD-401 using TransferAI agentic AI platform, Sofie.Partnership targets efficiency gains across regulatory workflows supporting Calidi plan to file CLD-401 IND by year end.CLD-401 is Calidi lead RedTail program, a systemically delivered virotherapy engineered to express IL-15 superagonist.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL3vVyr4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","IE00BN0W2V16.EUR","SG9999014039.USD","BK4112","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014005.SGD","BK4585","BK4588","IE00B64PRP62.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","BK4139","LU2210150020.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631956516","title":"Calidi Biotherapeutics Announces Strategic Partnership With Transferai to Drive Efficiencies in the Ind Submission Process for Cld-401 Using Agentic AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2631956516","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631956516?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:00","pubTimestamp":1777464003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUA6HJFSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631516135","title":"Calidi Biotherapeutics Inc - Expects Cld-401 Ind Filing by Year End","url":"https://stock-news.laohu8.com/highlight/detail?id=2631516135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631516135?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:00","pubTimestamp":1777464003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUA6HJFSH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631553990","title":"Calidi Biotherapeutics publishes RedTail platform presentation on systemic genetic medicine delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2631553990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631553990?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:40","pubTimestamp":1777423219,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics outlined RedTail, a vaccinia-virus platform designed for systemic delivery of genetic medicines with tumor-selective replication.Platform design aims to reduce immune clearance using extracellular enveloped virus production with CD55 overexpression.Calidi identified CLD-401 as lead program, a RedTail vector engineered for tumor-local IL-15 superagonist expression to drive tumor lysis and immune priming.Company expects IND filing for CLD-401 in 2026, targeting a Phase I monotherapy study in relapsed or refractory solid tumors.Calidi also highlighted partnering goals to license RedTail programs defined by tumor marker or genetic payloads, including constructs carrying up to 3 payloads.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL5FR4dn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629032074","title":"Calidi presents new data on CLD-401 at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2629032074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629032074?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:29","pubTimestamp":1776778188,"startTime":"0","endTime":"0","summary":"Calidi (CLDI) Biotherapeutics will present new data at the American Association of Cancer Research, AACR, annual meeting in San Diego, California o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calidi-presents-new-data-on-cld-401-at-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calidi-presents-new-data-on-cld-401-at-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628472535","title":"Calidi presents new data on in situ t-cell engagers at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2628472535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628472535?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:54","pubTimestamp":1776689678,"startTime":"0","endTime":"0","summary":"Calidi (CLDI) Biotherapeutics presented new data at the American Association of Cancer Research, AACR, annual meeting in San Diego, California on A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calidi-presents-new-data-on-in-situ-t-cell-engagers-at-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calidi-presents-new-data-on-in-situ-t-cell-engagers-at-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628174003","title":"Calidi presents preclinical data for RedTail-derived CLD-401, targets IND filing end-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628174003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628174003?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:07","pubTimestamp":1776686825,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics presented new preclinical data on April 19, 2026 at AACR on its RedTail platform designed to drive tumor-restricted expression of immune-activating payloads.Results showed RedTail constructs could support simultaneous T-cell activation and in-tumor production of a T-cell engager, an approach aimed at improving activity in solid tumors while limiting peripheral exposure.Calidi highlighted CLD-401 as lead RedTail candidate, positioning it to remodel tumor microenvironment and support localized immune activation.Company also advanced CLD-501, a TROP2-targeting in situ T-cell engager program intended to reduce off-tumor risk tied to that antigen.Calidi expects to file an IND for CLD-401 by end of 2026, setting up a potential clinical entry point for RedTail.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL3b26wS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","SG9999014013.SGD","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","BK4139","BK4585","NDAQ","LU2210150020.SGD","SG9999014021.USD","LU0314104364.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}]}}